TradeFlare's AI research teams analysed CB on 4 market nights between July 23, 2026 and August 17, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.
| Date | Verdict | Price | Target / stop | 5 days later | 20 days later | Why (that night) |
|---|---|---|---|---|---|---|
| August 17, 2026 | BUY | $343.64 | $367.20 / $319.59 | +1.5% | +0.3% | The technical setup suggests a short-term bounce opportunity, while the fundamental outlook supports longer-term upside. |
| August 14, 2026 | BUY | $344.50 | — / — | -0.8% | -0.5% | Strong fundamental performance and global insurance business operations. |
| August 13, 2026 | HOLD | $343.33 | — / — | -0.5% | -1.8% | Continued positive news sentiment driven by strong Q2 earnings and favorable analyst ratings. |
| July 23, 2026 | BUY | $343.23 | — / — | -0.9% | -2.9% | Strong Q2 earnings beat and increased shareholder returns. |
Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.